Determining Recommended Acceptable Intake Limits for N-Nitrosamine Impurities in Pharmaceuticals: Development and Application of the Carcinogenic Potency Categorization Approach (CPCA).
Kruhlak NL, Schmidt M, Froetschl R, Graber S, Haas B, Horne I, Horne S, King ST, Koval IA, Kumaran G, Langenkamp A, McGovern TJ, Peryea T, Sanh A, Ferreira AS, van Aerts L, Vespa A, Whomsley R.
Kruhlak NL, et al. Among authors: schmidt m.
Regul Toxicol Pharmacol. 2024 May 14:105640. doi: 10.1016/j.yrtph.2024.105640. Online ahead of print.
Regul Toxicol Pharmacol. 2024.
PMID: 38754805
Free article.